Natco challenges Gilead's patent on Tamiflu

Hyderabad-based Natco Pharma has challenged the patent for Tamiflu - a drug to treat bird flu - in the US.The company has sought the United States Food and Drug Administration (FDA)'s approval to......

Patent Office upholds Natco's plea

Drug maker Natco on Monday said that the Patent Office has upheld the firm's opposition to an application of Yeda Research & Development Company for patenting a generic version of a product of Teva......

Natco opposes Novartis patent claim

Natco Pharma has opposed an application made by Novartis India to the controller of patents, for grant of a patent for an anti-cancer drug 'Imatinib Mesylate'. The company has filed a pre-grant......

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......